APO Research
Talk to an analyst

APO RESEARCH · REPORT

Transdermal Drug Delivery System

Transdermal Drug Delivery System is a medicated adhesive patch that is placed on the skin to deliver a specific dose of medication through the skin and into the bloodstream. Often, this promotes healing to an injured area of the body. An advantage of a transdermal drug delivery route over other types of medication delivery such as oral, topical, intravenous, intramuscular, etc. is that the patch provides a controlled release of the medication into the patient, usually through either a porous membrane covering a reservoir of medication or through body heat melting thin layers of medication embedded in the adhesive.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Transdermal Drug Delivery System is a medicated adhesive patch that is placed on the skin to deliver a specific dose of medication through the skin and into the bloodstream. Often, this promotes healing to an injured area of the body. An advantage of a transdermal drug delivery route over other types of medication delivery such as oral, topical, intravenous, intramuscular, etc. is that the patch provides a controlled release of the medication into the patient, usually through either a porous membrane covering a reservoir of medication or through body heat melting thin layers of medication embedded in the adhesive.

Selected research

Market Analysis & Forecast

Global Transdermal Drug Delivery System Market Analysis and Forecast 2026-2032

9 January 2026205 pages

Choose your research edition.

Industry ResearchTransdermal Drug Delivery System Industry Research Report 2026131 pages · $2,950 USDIndustry Growth & TrendsGlobal Transdermal Drug Delivery System Industry Growth and Trends Forecast to 2032111 pages · $3,450 USDMarket StructureGlobal Transdermal Drug Delivery System Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Transdermal Drug Delivery System Market Outlook and Growth Opportunities 2026204 pages · $4,250 USDMarket Analysis & ForecastGlobal Transdermal Drug Delivery System Market Analysis and Forecast 2026-2032205 pages · $4,950 USD

Market perspective

Transdermal Drug Delivery System is a medicated adhesive patch that is placed on the skin to deliver a specific dose of medication through the skin and into the bloodstream. Often, this promotes healing to an injured area of the body. An advantage of a transdermal drug delivery route over other types of medication delivery such as oral, topical, intravenous, intramuscular, etc. is that the patch provides a controlled release of the medication into the patient, usually through either a porous membrane covering a reservoir of medication or through body heat melting thin layers of medication embedded in the adhesive.

Global Transdermal Drug Delivery System key players include Hisamitsu, Mylan, GSK, Novartis, Teve (Actavis), etc. Global top five manufacturers hold a share over 65%. North America is the largest market, with a share over 40%, followed by Europe and Asia-Pacific, both have a share over 45% percent.

In terms of product, Nitroglycerin is the largest segment, with a share over 25%. And in terms of application, the largest application is OTC, followed by RX.

Read the full market overview

Report Includes

This report presents an overview of global market for Transdermal Drug Delivery System, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Transdermal Drug Delivery System, also provides the revenue of main regions and countries. Of the upcoming market potential for Transdermal Drug Delivery System, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Transdermal Drug Delivery System revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Transdermal Drug Delivery System market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Transdermal Drug Delivery System revenue, projected growth trends, production technology, application and end-user industry.

Transdermal Drug Delivery System Segment by Company

Hisamitsu

Mylan

GSK

Novartis

Teve (Actavis)

Johnson & Johnson

Lohmann

Teikoku Seiyaku

Bayer

Lingrui

Sanofi

Qizheng

Endo

Huarun 999

Haw Par

Nichiban

Mentholatum

Laboratoires Genevrier

Transdermal Drug Delivery System Segment by Type

Fentanyl

Nitroglycerin

Estradiol

Nicotine

Other

Transdermal Drug Delivery System Segment by Application

OTC

Rx

Transdermal Drug Delivery System Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Transdermal Drug Delivery System market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Transdermal Drug Delivery System and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Transdermal Drug Delivery System.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Transdermal Drug Delivery System in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Transdermal Drug Delivery System company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Transdermal Drug Delivery System revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Transdermal Drug Delivery System Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Fentanyl Major Player Table 3. Nitroglycerin Major Player Table 4. Estradiol Major Player Table 5. Nicotine Major Player Table 6. Other Major Player Table 7. Global Transdermal Drug Delivery System Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 8. OTC Major Player Table 9. Rx Major Player Table 10. Transdermal Drug Delivery System Industry Trends Table 11. Transdermal Drug Delivery System Industry Drivers Table 12. Transdermal Drug Delivery System Industry Opportunities and Challenges Table 13. Transdermal Drug Delivery System Industry Restraints Table 14. Global Transdermal Drug Delivery System Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 15. Global Transdermal Drug Delivery System Market Size by Region (2021-2026) & (US$ Million) Table 16. Global Transdermal Drug Delivery System Market Share by Region (2021-2026) Table 17. Global Transdermal Drug Delivery System Market Size by Region (2027-2032) & (US$ Million) Table 18. Global Transdermal Drug Delivery System Market Share by Region (2027-2032) Table 19. Global Transdermal Drug Delivery System Revenue by Players (US$ Million) & (2021-2026) Table 20. Global Transdermal Drug Delivery System Revenue Market Share by Players (2021-2026) Table 21. Global Transdermal Drug Delivery System Key Players Ranking, 2024 VS 2025 VS 2026 Table 22. Global Transdermal Drug Delivery System Key Players Headquarters & Area Served Table 23. Global Transdermal Drug Delivery System Players, Product Type & Application Table 24. Global Transdermal Drug Delivery System Players Establishment Date Table 25. Global Players Market Concentration Ratio (CR5 and HHI) Table 26. Global Transdermal Drug Delivery System by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 27. Global Transdermal Drug Delivery System Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Transdermal Drug Delivery System Revenue by Type (2021-2026) & (US$ Million) Table 29. Global Transdermal Drug Delivery System Revenue by Type (2027-2032) & (US$ Million) Table 30. Global Transdermal Drug Delivery System Revenue Market Share by Type (2021-2026) Table 31. Global Transdermal Drug Delivery System Revenue Market Share by Type (2027-2032) Table 32. Global Transdermal Drug Delivery System Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Transdermal Drug Delivery System Revenue by Application (2021-2026) & (US$ Million) Table 34. Global Transdermal Drug Delivery System Revenue by Application (2027-2032) & (US$ Million) Table 35. Global Transdermal Drug Delivery System Revenue Market Share by Application (2021-2026) Table 36. Global Transdermal Drug Delivery System Revenue Market Share by Application (2027-2032) Table 37. Hisamitsu Company Information Table 38. Hisamitsu Business Overview Table 39. Hisamitsu Transdermal Drug Delivery System Revenue and Gross Margin (US$ Million) & (2021-2026) Table 40. Hisamitsu Transdermal Drug Delivery System Product Portfolio Table 41. Hisamitsu Recent Development Table 42. Mylan Company Information Table 43. Mylan Business Overview Table 44. Mylan Transdermal Drug Delivery System Revenue and Gross Margin (US$ Million) & (2021-2026) Table 45. Mylan Transdermal Drug Delivery System Product Portfolio Table 46. Mylan Recent Development Table 47. GSK Company Information Table 48. GSK Business Overview Table 49. GSK Transdermal Drug Delivery System Revenue and Gross Margin (US$ Million) & (2021-2026) Table 50. GSK Transdermal Drug Delivery System Product Portfolio Table 51. GSK Recent Development Table 52. Novartis Company Information Table 53. Novartis Business Overview Table 54. Novartis Transdermal Drug Delivery System Revenue and Gross Margin (US$ Million) & (2021-2026) Table 55. Novartis Transdermal Drug Delivery System Product Portfolio Table 56. Novartis Recent Development Table 57. Teve (Actavis) Company Information Table 58. Teve (Actavis) Business Overview Table 59. Teve (Actavis) Transdermal Drug Delivery System Revenue and Gross Margin (US$ Million) & (2021-2026) Table 60. Teve (Actavis) Transdermal Drug Delivery System Product Portfolio Table 61. Teve (Actavis) Recent Development Table 62. Johnson & Johnson Company Information Table 63. Johnson & Johnson Business Overview Table 64. Johnson & Johnson Transdermal Drug Delivery System Revenue and Gross Margin (US$ Million) & (2021-2026) Table 65. Johnson & Johnson Transdermal Drug Delivery System Product Portfolio Table 66. Johnson & Johnson Recent Development Table 67. Lohmann Company Information Table 68. Lohmann Business Overview Table 69. Lohmann Transdermal Drug Delivery System Revenue and Gross Margin (US$ Million) & (2021-2026) Table 70. Lohmann Transdermal Drug Delivery System Product Portfolio Table 71. Lohmann Recent Development Table 72. Teikoku Seiyaku Company Information Table 73. Teikoku Seiyaku Business Overview Table 74. Teikoku Seiyaku Transdermal Drug Delivery System Revenue and Gross Margin (US$ Million) & (2021-2026) Table 75. Teikoku Seiyaku Transdermal Drug Delivery System Product Portfolio Table 76. Teikoku Seiyaku Recent Development Table 77. Bayer Company Information Table 78. Bayer Business Overview Table 79. Bayer Transdermal Drug Delivery System Revenue and Gross Margin (US$ Million) & (2021-2026) Table 80. Bayer Transdermal Drug Delivery System Product Portfolio Table 81. Bayer Recent Development Table 82. Lingrui Company Information Table 83. Lingrui Business Overview Table 84. Lingrui Transdermal Drug Delivery System Revenue and Gross Margin (US$ Million) & (2021-2026) Table 85. Lingrui Transdermal Drug Delivery System Product Portfolio Table 86. Lingrui Recent Development Table 87. Sanofi Company Information Table 88. Sanofi Business Overview Table 89. Sanofi Transdermal Drug Delivery System Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 90. Sanofi Transdermal Drug Delivery System Product Portfolio Table 91. Sanofi Recent Development Table 92. Qizheng Company Information Table 93. Qizheng Business Overview Table 94. Qizheng Transdermal Drug Delivery System Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 95. Qizheng Transdermal Drug Delivery System Product Portfolio Table 96. Qizheng Recent Development Table 97. Endo Company Information Table 98. Endo Business Overview Table 99. Endo Transdermal Drug Delivery System Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 100. Endo Transdermal Drug Delivery System Product Portfolio Table 101. Endo Recent Development Table 102. Huarun 999 Company Information Table 103. Huarun 999 Business Overview Table 104. Huarun 999 Transdermal Drug Delivery System Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 105. Huarun 999 Transdermal Drug Delivery System Product Portfolio Table 106. Huarun 999 Recent Development Table 107. Haw Par Company Information Table 108. Haw Par Business Overview Table 109. Haw Par Transdermal Drug Delivery System Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 110. Haw Par Transdermal Drug Delivery System Product Portfolio Table 111. Haw Par Recent Development Table 112. Nichiban Company Information Table 113. Nichiban Business Overview Table 114. Nichiban Transdermal Drug Delivery System Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 115. Nichiban Transdermal Drug Delivery System Product Portfolio Table 116. Nichiban Recent Development Table 117. Mentholatum Company Information Table 118. Mentholatum Business Overview Table 119. Mentholatum Transdermal Drug Delivery System Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 120. Mentholatum Transdermal Drug Delivery System Product Portfolio Table 121. Mentholatum Recent Development Table 122. Laboratoires Genevrier Company Information Table 123. Laboratoires Genevrier Business Overview Table 124. Laboratoires Genevrier Transdermal Drug Delivery System Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 125. Laboratoires Genevrier Transdermal Drug Delivery System Product Portfolio Table 126. Laboratoires Genevrier Recent Development Table 127. North America Transdermal Drug Delivery System Revenue by Type (2021-2026) & (US$ Million) Table 128. North America Transdermal Drug Delivery System Revenue by Type (2027-2032) & (US$ Million) Table 129. North America Transdermal Drug Delivery System Revenue by Application (2021-2026) & (US$ Million) Table 130. North America Transdermal Drug Delivery System Revenue by Application (2027-2032) & (US$ Million) Table 131. North America Transdermal Drug Delivery System Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 132. North America Transdermal Drug Delivery System Revenue by Country (2021-2026) & (US$ Million) Table 133. North America Transdermal Drug Delivery System Revenue by Country (US$ Million) & (2027-2032) Table 134. Europe Transdermal Drug Delivery System Revenue by Type (2021-2026) & (US$ Million) Table 135. Europe Transdermal Drug Delivery System Revenue by Type (2027-2032) & (US$ Million) Table 136. Europe Transdermal Drug Delivery System Revenue by Application (2021-2026) & (US$ Million) Table 137. Europe Transdermal Drug Delivery System Revenue by Application (2027-2032) & (US$ Million) Table 138. Europe Transdermal Drug Delivery System Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 139. Europe Transdermal Drug Delivery System Revenue by Country (2021-2026) & (US$ Million) Table 140. Europe Transdermal Drug Delivery System Revenue by Country (US$ Million) & (2027-2032) Table 141. China Transdermal Drug Delivery System Revenue by Type (2021-2026) & (US$ Million) Table 142. China Transdermal Drug Delivery System Revenue by Type (2027-2032) & (US$ Million) Table 143. China Transdermal Drug Delivery System Revenue by Application (2021-2026) & (US$ Million) Table 144. China Transdermal Drug Delivery System Revenue by Application (2027-2032) & (US$ Million) Table 145. Asia Transdermal Drug Delivery System Revenue by Type (2021-2026) & (US$ Million) Table 146. Asia Transdermal Drug Delivery System Revenue by Type (2027-2032) & (US$ Million) Table 147. Asia Transdermal Drug Delivery System Revenue by Application (2021-2026) & (US$ Million) Table 148. Asia Transdermal Drug Delivery System Revenue by Application (2027-2032) & (US$ Million) Table 149. Asia Transdermal Drug Delivery System Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 150. Asia Transdermal Drug Delivery System Revenue by Region (US$ Million) & (2021-2026) Table 151. Asia Transdermal Drug Delivery System Revenue by Region (US$ Million) & (2027-2032) Table 152. SAMEA Transdermal Drug Delivery System Revenue by Type (2021-2026) & (US$ Million) Table 153. SAMEA Transdermal Drug Delivery System Revenue by Type (2027-2032) & (US$ Million) Table 154. SAMEA Transdermal Drug Delivery System Revenue by Application (2021-2026) & (US$ Million) Table 155. SAMEA Transdermal Drug Delivery System Revenue by Application (2027-2032) & (US$ Million) Table 156. SAMEA Transdermal Drug Delivery System Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 157. SAMEA Transdermal Drug Delivery System Revenue by Country (2021-2026) & (US$ Million) Table 158. SAMEA Transdermal Drug Delivery System Revenue by Country (US$ Million) & (2027-2032) Table 159. Research Programs/Design for This Report Table 160. Authors List of This Report Table 161. Secondary Sources Table 162. Primary Sources List of Figures Figure 1. Transdermal Drug Delivery System Image Figure 2. Global Transdermal Drug Delivery System Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Transdermal Drug Delivery System Market Size Share 2021 VS 2025 VS 2032 Figure 4. Fentanyl Image Figure 5. Nitroglycerin Image Figure 6. Estradiol Image Figure 7. Nicotine Image Figure 8. Other Image Figure 9. Global Transdermal Drug Delivery System Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 10. Global Transdermal Drug Delivery System Market Size Share 2021 VS 2025 VS 2032 Figure 11. OTC Image Figure 12. Rx Image Figure 13. Global Transdermal Drug Delivery System Market Size (US$ Million) & (2021-2032) Figure 14. Global Transdermal Drug Delivery System Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Transdermal Drug Delivery System Market Share by Region: 2021 VS 2025 VS 2032 Figure 16. Global Transdermal Drug Delivery System Players Revenue Share Top 10 and Top 5 in 2025 Figure 17. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global Transdermal Drug Delivery System Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Transdermal Drug Delivery System Revenue Market Share 2021 VS 2025 VS 2032 Figure 20. Global Transdermal Drug Delivery System Revenue Market Share by Type (2021-2032) Figure 21. Global Transdermal Drug Delivery System Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Transdermal Drug Delivery System Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 23. Global Transdermal Drug Delivery System Revenue Market Share by Application (2021-2032) Figure 24. North America Transdermal Drug Delivery System Revenue YoY Growth (2021-2032) & (US$ Million) Figure 25. North America Transdermal Drug Delivery System Revenue Share by Type (2021-2032) Figure 26. North America Transdermal Drug Delivery System Revenue Share by Application (2021-2032) Figure 27. North America Transdermal Drug Delivery System Revenue Share by Country (2021-2032) Figure 28. United States Transdermal Drug Delivery System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Canada Transdermal Drug Delivery System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Mexico Transdermal Drug Delivery System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Europe Transdermal Drug Delivery System Revenue YoY Growth (2021-2032) & (US$ Million) Figure 32. Europe Transdermal Drug Delivery System Revenue Share by Type (2021-2032) Figure 33. Europe Transdermal Drug Delivery System Revenue Share by Application (2021-2032) Figure 34. Europe Transdermal Drug Delivery System Revenue Share by Country (2021-2032) Figure 35. Germany Transdermal Drug Delivery System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. France Transdermal Drug Delivery System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. U.K. Transdermal Drug Delivery System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Italy Transdermal Drug Delivery System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Spain Transdermal Drug Delivery System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Russia Transdermal Drug Delivery System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Netherlands Transdermal Drug Delivery System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Nordic Countries Transdermal Drug Delivery System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. China Transdermal Drug Delivery System Revenue YoY Growth (2021-2032) & (US$ Million) Figure 44. China Transdermal Drug Delivery System Revenue Share by Type (2021-2032) Figure 45. China Transdermal Drug Delivery System Revenue Share by Application (2021-2032) Figure 46. Asia Transdermal Drug Delivery System Revenue YoY Growth (2021-2032) & (US$ Million) Figure 47. Asia Transdermal Drug Delivery System Revenue Share by Type (2021-2032) Figure 48. Asia Transdermal Drug Delivery System Revenue Share by Application (2021-2032) Figure 49. Asia Transdermal Drug Delivery System Revenue Share by Region (2021-2032) Figure 50. Japan Transdermal Drug Delivery System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. South Korea Transdermal Drug Delivery System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. India Transdermal Drug Delivery System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Australia Transdermal Drug Delivery System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Taiwan Transdermal Drug Delivery System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Southeast Asia Transdermal Drug Delivery System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. SAMEA Transdermal Drug Delivery System Revenue YoY Growth (2021-2032) & (US$ Million) Figure 57. SAMEA Transdermal Drug Delivery System Revenue Share by Type (2021-2032) Figure 58. SAMEA Transdermal Drug Delivery System Revenue Share by Application (2021-2032) Figure 59. SAMEA Transdermal Drug Delivery System Revenue Share by Country (2021-2032) Figure 60. Brazil Transdermal Drug Delivery System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Argentina Transdermal Drug Delivery System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Chile Transdermal Drug Delivery System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Colombia Transdermal Drug Delivery System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Peru Transdermal Drug Delivery System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Saudi Arabia Transdermal Drug Delivery System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Israel Transdermal Drug Delivery System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. UAE Transdermal Drug Delivery System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Turkey Transdermal Drug Delivery System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Iran Transdermal Drug Delivery System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Egypt Transdermal Drug Delivery System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Fentanyl
  • Nitroglycerin
  • Estradiol
  • Nicotine
  • Other
Applications
  • OTC
  • Rx
Companies covered
  • Hisamitsu
  • Mylan
  • GSK
  • Novartis
  • Teve (Actavis)
  • Johnson & Johnson
  • Lohmann
  • Teikoku Seiyaku
  • Bayer
  • Lingrui
  • Sanofi
  • Qizheng
  • Endo
  • Huarun 999
  • Haw Par
  • Nichiban
  • Mentholatum
  • Laboratoires Genevrier

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Transdermal Drug Delivery System Market by Type
  3. 1.2.1 Global Transdermal Drug Delivery System Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Fentanyl
  5. 1.2.3 Nitroglycerin
  6. 1.2.4 Estradiol
  7. 1.2.5 Nicotine
  8. 1.2.6 Other
  9. 1.3 Transdermal Drug Delivery System Market by Application
  10. 1.3.1 Global Transdermal Drug Delivery System Market Size by Application, 2021 VS 2025 VS 2032
  11. 1.3.2 OTC
  12. 1.3.3 Rx
  13. 1.4 Assumptions and Limitations
  14. 1.5 Study Goals and Objectives
2 Transdermal Drug Delivery System Market Dynamics
  1. 2.1 Transdermal Drug Delivery System Industry Trends
  2. 2.2 Transdermal Drug Delivery System Industry Drivers
  3. 2.3 Transdermal Drug Delivery System Industry Opportunities and Challenges
  4. 2.4 Transdermal Drug Delivery System Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Transdermal Drug Delivery System Market Perspective (2021-2032)
  2. 3.2 Global Transdermal Drug Delivery System Growth Trends by Region
  3. 3.2.1 Global Transdermal Drug Delivery System Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Transdermal Drug Delivery System Market Size by Region (2021-2026)
  5. 3.2.3 Global Transdermal Drug Delivery System Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Transdermal Drug Delivery System Revenue by Players
  2. 4.1.1 Global Transdermal Drug Delivery System Revenue by Players (2021-2026)
  3. 4.1.2 Global Transdermal Drug Delivery System Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Transdermal Drug Delivery System Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Transdermal Drug Delivery System Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Transdermal Drug Delivery System Key Players Headquarters & Area Served
  7. 4.4 Global Transdermal Drug Delivery System Players, Product Type & Application
  8. 4.5 Global Transdermal Drug Delivery System Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Transdermal Drug Delivery System Market CR5 and HHI
  11. 4.6.3 2025 Transdermal Drug Delivery System Tier 1, Tier 2, and Tier 3
5 Transdermal Drug Delivery System Market Size by Type
  1. 5.1 Global Transdermal Drug Delivery System Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Transdermal Drug Delivery System Revenue by Type (2021-2032)
  3. 5.3 Global Transdermal Drug Delivery System Revenue Market Share by Type (2021-2032)
6 Transdermal Drug Delivery System Market Size by Application
  1. 6.1 Global Transdermal Drug Delivery System Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Transdermal Drug Delivery System Revenue by Application (2021-2032)
  3. 6.3 Global Transdermal Drug Delivery System Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Hisamitsu
  2. 7.1.1 Hisamitsu Company Information
  3. 7.1.2 Hisamitsu Business Overview
  4. 7.1.3 Hisamitsu Transdermal Drug Delivery System Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Hisamitsu Transdermal Drug Delivery System Product Portfolio
  6. 7.1.5 Hisamitsu Recent Developments
  7. 7.2 Mylan
  8. 7.2.1 Mylan Company Information
  9. 7.2.2 Mylan Business Overview
  10. 7.2.3 Mylan Transdermal Drug Delivery System Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Mylan Transdermal Drug Delivery System Product Portfolio
  12. 7.2.5 Mylan Recent Developments
  13. 7.3 GSK
  14. 7.3.1 GSK Company Information
  15. 7.3.2 GSK Business Overview
  16. 7.3.3 GSK Transdermal Drug Delivery System Revenue and Gross Margin (2021-2026)
  17. 7.3.4 GSK Transdermal Drug Delivery System Product Portfolio
  18. 7.3.5 GSK Recent Developments
  19. 7.4 Novartis
  20. 7.4.1 Novartis Company Information
  21. 7.4.2 Novartis Business Overview
  22. 7.4.3 Novartis Transdermal Drug Delivery System Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Novartis Transdermal Drug Delivery System Product Portfolio
  24. 7.4.5 Novartis Recent Developments
  25. 7.5 Teve (Actavis)
  26. 7.5.1 Teve (Actavis) Company Information
  27. 7.5.2 Teve (Actavis) Business Overview
  28. 7.5.3 Teve (Actavis) Transdermal Drug Delivery System Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Teve (Actavis) Transdermal Drug Delivery System Product Portfolio
  30. 7.5.5 Teve (Actavis) Recent Developments
  31. 7.6 Johnson & Johnson
  32. 7.6.1 Johnson & Johnson Company Information
  33. 7.6.2 Johnson & Johnson Business Overview
  34. 7.6.3 Johnson & Johnson Transdermal Drug Delivery System Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Johnson & Johnson Transdermal Drug Delivery System Product Portfolio
  36. 7.6.5 Johnson & Johnson Recent Developments
  37. 7.7 Lohmann
  38. 7.7.1 Lohmann Company Information
  39. 7.7.2 Lohmann Business Overview
  40. 7.7.3 Lohmann Transdermal Drug Delivery System Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Lohmann Transdermal Drug Delivery System Product Portfolio
  42. 7.7.5 Lohmann Recent Developments
  43. 7.8 Teikoku Seiyaku
  44. 7.8.1 Teikoku Seiyaku Company Information
  45. 7.8.2 Teikoku Seiyaku Business Overview
  46. 7.8.3 Teikoku Seiyaku Transdermal Drug Delivery System Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Teikoku Seiyaku Transdermal Drug Delivery System Product Portfolio
  48. 7.8.5 Teikoku Seiyaku Recent Developments
  49. 7.9 Bayer
  50. 7.9.1 Bayer Company Information
  51. 7.9.2 Bayer Business Overview
  52. 7.9.3 Bayer Transdermal Drug Delivery System Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Bayer Transdermal Drug Delivery System Product Portfolio
  54. 7.9.5 Bayer Recent Developments
  55. 7.10 Lingrui
  56. 7.10.1 Lingrui Company Information
  57. 7.10.2 Lingrui Business Overview
  58. 7.10.3 Lingrui Transdermal Drug Delivery System Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Lingrui Transdermal Drug Delivery System Product Portfolio
  60. 7.10.5 Lingrui Recent Developments
  61. 7.11 Sanofi
  62. 7.11.1 Sanofi Company Information
  63. 7.11.2 Sanofi Business Overview
  64. 7.11.3 Sanofi Transdermal Drug Delivery System Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Sanofi Transdermal Drug Delivery System Product Portfolio
  66. 7.11.5 Sanofi Recent Developments
  67. 7.12 Qizheng
  68. 7.12.1 Qizheng Company Information
  69. 7.12.2 Qizheng Business Overview
  70. 7.12.3 Qizheng Transdermal Drug Delivery System Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Qizheng Transdermal Drug Delivery System Product Portfolio
  72. 7.12.5 Qizheng Recent Developments
  73. 7.13 Endo
  74. 7.13.1 Endo Company Information
  75. 7.13.2 Endo Business Overview
  76. 7.13.3 Endo Transdermal Drug Delivery System Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Endo Transdermal Drug Delivery System Product Portfolio
  78. 7.13.5 Endo Recent Developments
  79. 7.14 Huarun 999
  80. 7.14.1 Huarun 999 Company Information
  81. 7.14.2 Huarun 999 Business Overview
  82. 7.14.3 Huarun 999 Transdermal Drug Delivery System Revenue and Gross Margin (2021-2026)
  83. 7.14.4 Huarun 999 Transdermal Drug Delivery System Product Portfolio
  84. 7.14.5 Huarun 999 Recent Developments
  85. 7.15 Haw Par
  86. 7.15.1 Haw Par Company Information
  87. 7.15.2 Haw Par Business Overview
  88. 7.15.3 Haw Par Transdermal Drug Delivery System Revenue and Gross Margin (2021-2026)
  89. 7.15.4 Haw Par Transdermal Drug Delivery System Product Portfolio
  90. 7.15.5 Haw Par Recent Developments
  91. 7.16 Nichiban
  92. 7.16.1 Nichiban Company Information
  93. 7.16.2 Nichiban Business Overview
  94. 7.16.3 Nichiban Transdermal Drug Delivery System Revenue and Gross Margin (2021-2026)
  95. 7.16.4 Nichiban Transdermal Drug Delivery System Product Portfolio
  96. 7.16.5 Nichiban Recent Developments
  97. 7.17 Mentholatum
  98. 7.17.1 Mentholatum Company Information
  99. 7.17.2 Mentholatum Business Overview
  100. 7.17.3 Mentholatum Transdermal Drug Delivery System Revenue and Gross Margin (2021-2026)
  101. 7.17.4 Mentholatum Transdermal Drug Delivery System Product Portfolio
  102. 7.17.5 Mentholatum Recent Developments
  103. 7.18 Laboratoires Genevrier
  104. 7.18.1 Laboratoires Genevrier Company Information
  105. 7.18.2 Laboratoires Genevrier Business Overview
  106. 7.18.3 Laboratoires Genevrier Transdermal Drug Delivery System Revenue and Gross Margin (2021-2026)
  107. 7.18.4 Laboratoires Genevrier Transdermal Drug Delivery System Product Portfolio
  108. 7.18.5 Laboratoires Genevrier Recent Developments
8 North America
  1. 8.1 North America Transdermal Drug Delivery System Revenue (2021-2032)
  2. 8.2 North America Transdermal Drug Delivery System Revenue by Type (2021-2032)
  3. 8.2.1 North America Transdermal Drug Delivery System Revenue by Type (2021-2026)
  4. 8.2.2 North America Transdermal Drug Delivery System Revenue by Type (2027-2032)
  5. 8.3 North America Transdermal Drug Delivery System Revenue Share by Type (2021-2032)
  6. 8.4 North America Transdermal Drug Delivery System Revenue by Application (2021-2032)
  7. 8.4.1 North America Transdermal Drug Delivery System Revenue by Application (2021-2026)
  8. 8.4.2 North America Transdermal Drug Delivery System Revenue by Application (2027-2032)
  9. 8.5 North America Transdermal Drug Delivery System Revenue Share by Application (2021-2032)
  10. 8.6 North America Transdermal Drug Delivery System Revenue by Country
  11. 8.6.1 North America Transdermal Drug Delivery System Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Transdermal Drug Delivery System Revenue by Country (2021-2026)
  13. 8.6.3 North America Transdermal Drug Delivery System Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Transdermal Drug Delivery System Revenue (2021-2032)
  2. 9.2 Europe Transdermal Drug Delivery System Revenue by Type (2021-2032)
  3. 9.2.1 Europe Transdermal Drug Delivery System Revenue by Type (2021-2026)
  4. 9.2.2 Europe Transdermal Drug Delivery System Revenue by Type (2027-2032)
  5. 9.3 Europe Transdermal Drug Delivery System Revenue Share by Type (2021-2032)
  6. 9.4 Europe Transdermal Drug Delivery System Revenue by Application (2021-2032)
  7. 9.4.1 Europe Transdermal Drug Delivery System Revenue by Application (2021-2026)
  8. 9.4.2 Europe Transdermal Drug Delivery System Revenue by Application (2027-2032)
  9. 9.5 Europe Transdermal Drug Delivery System Revenue Share by Application (2021-2032)
  10. 9.6 Europe Transdermal Drug Delivery System Revenue by Country
  11. 9.6.1 Europe Transdermal Drug Delivery System Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Transdermal Drug Delivery System Revenue by Country (2021-2026)
  13. 9.6.3 Europe Transdermal Drug Delivery System Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Transdermal Drug Delivery System Revenue (2021-2032)
  2. 10.2 China Transdermal Drug Delivery System Revenue by Type (2021-2032)
  3. 10.2.1 China Transdermal Drug Delivery System Revenue by Type (2021-2026)
  4. 10.2.2 China Transdermal Drug Delivery System Revenue by Type (2027-2032)
  5. 10.3 China Transdermal Drug Delivery System Revenue Share by Type (2021-2032)
  6. 10.4 China Transdermal Drug Delivery System Revenue by Application (2021-2032)
  7. 10.4.1 China Transdermal Drug Delivery System Revenue by Application (2021-2026)
  8. 10.4.2 China Transdermal Drug Delivery System Revenue by Application (2027-2032)
  9. 10.5 China Transdermal Drug Delivery System Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Transdermal Drug Delivery System Revenue (2021-2032)
  2. 11.2 Asia Transdermal Drug Delivery System Revenue by Type (2021-2032)
  3. 11.2.1 Asia Transdermal Drug Delivery System Revenue by Type (2021-2026)
  4. 11.2.2 Asia Transdermal Drug Delivery System Revenue by Type (2027-2032)
  5. 11.3 Asia Transdermal Drug Delivery System Revenue Share by Type (2021-2032)
  6. 11.4 Asia Transdermal Drug Delivery System Revenue by Application (2021-2032)
  7. 11.4.1 Asia Transdermal Drug Delivery System Revenue by Application (2021-2026)
  8. 11.4.2 Asia Transdermal Drug Delivery System Revenue by Application (2027-2032)
  9. 11.5 Asia Transdermal Drug Delivery System Revenue Share by Application (2021-2032)
  10. 11.6 Asia Transdermal Drug Delivery System Revenue by Country
  11. 11.6.1 Asia Transdermal Drug Delivery System Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Transdermal Drug Delivery System Revenue by Country (2021-2026)
  13. 11.6.3 Asia Transdermal Drug Delivery System Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Transdermal Drug Delivery System Revenue (2021-2032)
  2. 12.2 SAMEA Transdermal Drug Delivery System Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Transdermal Drug Delivery System Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Transdermal Drug Delivery System Revenue by Type (2027-2032)
  5. 12.3 SAMEA Transdermal Drug Delivery System Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Transdermal Drug Delivery System Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Transdermal Drug Delivery System Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Transdermal Drug Delivery System Revenue by Application (2027-2032)
  9. 12.5 SAMEA Transdermal Drug Delivery System Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Transdermal Drug Delivery System Revenue by Country
  11. 12.6.1 SAMEA Transdermal Drug Delivery System Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Transdermal Drug Delivery System Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Transdermal Drug Delivery System Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst